Innehållet på denna webbplats är endast avsett för veterinärer eller andra professionella inom djurhälsovård.
Genom att använda denna webbplats accepterar du ovanstående.
Intervacc’s Chief Scientific Officer Dr Andrew Waller participate at the Dutch Equine Conference
Stockholm, November 24, 2022 – The Dutch Equine Conference is one of the Benelux region equine veterinary profession’s events, and it is back again this year! Intervacc’s Chief Scientific Officer Dr Andrew Waller will participate in two sessions about the...Intervacc’s Chief Scientific Officer Dr Andrew Waller will speak about the prevention of equine strangles at the London Vet Show
Stockholm, November 16, 2022 – The London Vet Show is one of the veterinary profession’s favourite events, and it is back again this year! Intervacc’s Chief Scientific Officer Dr Andrew Waller will speak in a CPD (Continuing Professional Development) session...Strangvac sales to start in Ireland
Stockholm, November 15, 2022 – Strangvac® is being shipped to wholesalers in Ireland this week and veterinarians will soon begin to vaccinate horses in Ireland against Strangles. Ireland, often referred to as the ‘Land of the Horse’, is one of the world’s...Nomination Committee appointed in respect of AGM 2023 in Intervacc
Stockholm, November 11, 2022 – According to the principles for the appointment of the Nomination Committee in Intervacc AB (publ) adopted at the annual general meeting held on June 14th, 2022, the Nomination Committee for the annual general meeting 2023 shall be...Interim report January – September 2022
The period in summary Third quarter July 1 – September 30, 2022 On July 20th, 2022 Intervacc announced that the company had received an order for the equivalent of approximately SEK 3 million from Dechra Pharmaceuticals PLC. The order concerns delivery of Strangvac®...Nyhetstjänster
